EndoGastric Solutions closes $45M funding round — 3 insights

EndoGastric Solutions closed a $45 million series I round to fuel commercialization efforts around its TIF 2.0 procedure.

What you should know:

1. Growth capital medical device investor Accelmed led the round.

2. Accelmed co-founder and managing partner Uri Geiger, PhD, will join EndoGastric Solutions' board.

3. EndoGastric Solutions previously closed a $30.5 million funding round in July 2018.
https://www.businesswire.com/news/home/20180710005599/en/EndoGastric-Solutions-Secures-30.5-Million-New-Financing

"With the closing of this round, we have established a strong financial foundation from which to leverage the significant growth opportunities ahead of us and achieve long-term commercial viability," said EndoGastric Solutions President and CEO Skip Baldino.

More articles on gastroenterology:
Now-defunct Laser Spine Institute under fire over insurance handling — 5 key details
Washington passes surprise-billing law
3 ways ASCs can improve cash flow 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

ASC_GI_300x250

Featured Webinars

Featured Whitepapers

Featured Podcast